Natalia Lazorko

1 ta ish

Tashkent Pediatric Medical Institute

1. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

   Olga Kulemina, Julia Yakovleva, Natalia Lazorko +6

   MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

   ABIABI:AkademIndex/2023.article.010138